News
The Finnish Cancer Institute in collaboration with the K Albin Johansson Foundation has opened nine research positions: • Three Research Professors (EUR 6500/mo) • Three Cancer Research Fellows (EUR 5000/mo) …
Mika Mustonen from ORION (ORN) has been selected as new Director of FICAN South – one of the five nodes of the Finnish National Cancer Center to be established in …
Helsinki Innovation Services is hiring a Business Development Director Digital Precision Cancer Medicine This opportunity is for a dynamic, brave and independent commercialisation enthusiast eager to work with top scientists …
Commissioner Carlos Moedas announced iCAN Executive Officer Tomi Mäkelä is selected to the Mission Board for Cancer. Cancer was selected earlier this year as one of the five European missions …
The challenge of our time
Cancer is a growing threat to our global health. The scientific community and society at large are investing heavily to improve prevention, detection, survival, and quality of life of cancer patients. Precision Cancer Medicine represents a highly promising approach to tackle this global challenge, but there are still a number of bottlenecks.
Our approach
Combining precision cancer medicine and digital health.
Our approach is based on integrating molecular data with digital health data in new and meaningful ways. Sounds quite straight forward, right? But rest assured, it is a highly challenging task. The good news is that Finland has globally unique assets for actually making this happen.
For patients
Improved treatments and quality of life for cancer patients through innovative research – empowerment by working together.
For researchers
Bring your skills to iCAN to enable breakthrough science at the intersection of precision cancer medicine and digital health.
For partners
Join iCAN competence cluster to contribute and impact how the digital precision cancer medicine goes for solutions.
Empowering patients in cancer care and research
Introducing iCAN
iCAN is an innovative multidisciplinary initiative
that brings together some of the world’s leading actors in cancer genomics,
translational and clinical cancer research, digital health, information technology,
machine learning and business to solve one of the most pressing challenges of our time – cancer.
This unique ecosystem will be based on two national cancer research Centers of Excellence
at the University of Helsinki and the first Nordic Comprehensive Cancer Center at Helsinki University Hospital HUS with an aim to synergize with the national cancer center FICAN and its regional node FICAN South.
Join the iCAN community
iCAN is still forming its ways to operate, and therefore…
We would really appreciate your input either here or at our upcoming events. As presented at the kick-off May 29, we are currently developing engagement opportunities for companies to join and would be very interested in discussing this with you.
